Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detailed Study on the Safety, Dosage and Feasibility of an Intervention Based on a Computerized Cognitive Training (CCT) for Individuals With Post-acute Sequelae of COVID-19 (PASC): A Phase I/II Trial

NCT05582603 is registered in ClinicalTrials.gov with Universidad Antonio de Nebrija as lead sponsor.

NCT NCT05582603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05582603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detailed Study on the Safety, Dosage and Feasibility of an Intervention Based on a Computerized Cognitive Training (CCT) for Individuals With Post-acute Sequelae of COVID-19 (PASC): A Phase I/II Trial
Lead sponsor
Universidad Antonio de Nebrija
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 18, 2022
Completion date
November 30, 2022
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, cognitive impairment, post acute covid-19 syndrome, post-acute covid-19